Capital Health Radiology Services announced a new milestone in patient care with the implementation of Annalise Critical Care AI, an innovative artificial intelligence radiology solution from Annalise.ai that is now operational in Capital Health Medical Center – Hopewell and Capital Health Regional Medical Center. Approved by the United States Food and Drug Administration (FDA), this cutting-edge technology helps ensure that critical findings get prioritized almost instantly, elevating clinicians’ approach to patient diagnosis and care.

Annalise Critical Care AI is a support tool for radiologists that ensures that no critical exam sits at the bottom of a worklist waiting for review. Instead, this advanced diagnostic solution monitors all chest X-rays and non-contrast head CT exams automatically at high speed for critical findings. Upon detection of a time-sensitive condition, Annalise prioritizes and notifies Capital Health radiologists so immediate action can be taken for patients when they need it most.

“Capital Health Radiology Services is proud to lead the way in using cutting-edge technology to revolutionize patient care,” said Dr. Ajay Choudhri, chairman and medical director of Capital Health’s Department of Radiology. “Implementing Annalise Critical Care AI marks, a significant leap forward in our mission to provide the highest quality care to our patients. By helping our radiologists swiftly detect a range of critical conditions, this innovative technology allows the broader care team to safely achieve better outcomes and peace of mind for patients.”

“Annalise.ai has been proactive in recognizing the challenges faced by radiologists, including imaging backlogs and other challenges,” said Dimitry Tran, Deputy CEO and co-founder of Annalise.ai. “By expediting regulatory approvals, Annalise.ai has had 12 findings cleared by the FDA cleared in under two years. This aligns perfectly with Annalise.ai’s commitment to enhancing workflow efficiency and productivity in the U.S. radiology landscape.”